Explore the detailed record of transactions filed by Stueland Katherine, Chief Executive Officer. Insider active across 2 companies, notably GeneDx Holdings Corp.. Aggregated, 6 disclosures have been recorded. Total volume traded: €599k. The latest transaction was filed on 3 March 2026 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Katherine Stueland is the Chief Executive Officer at GeneDx Holdings Corp. and Invitae Corp. She leads business operations and is responsible for the company's growth strategy. With a strong background in the healthcare sector, Katherine Stueland is committed to innovation and improving the services offered by the companies. Her leadership is essential for achieving performance and development objectives.